1. Home
  2. GRFS vs MCY Comparison

GRFS vs MCY Comparison

Compare GRFS & MCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GRFS
  • MCY
  • Stock Information
  • Founded
  • GRFS 1940
  • MCY 1961
  • Country
  • GRFS Spain
  • MCY United States
  • Employees
  • GRFS N/A
  • MCY N/A
  • Industry
  • GRFS Biotechnology: Pharmaceutical Preparations
  • MCY Property-Casualty Insurers
  • Sector
  • GRFS Health Care
  • MCY Finance
  • Exchange
  • GRFS Nasdaq
  • MCY Nasdaq
  • Market Cap
  • GRFS 5.9B
  • MCY 4.9B
  • IPO Year
  • GRFS 2006
  • MCY N/A
  • Fundamental
  • Price
  • GRFS $8.39
  • MCY $92.95
  • Analyst Decision
  • GRFS Hold
  • MCY Strong Buy
  • Analyst Count
  • GRFS 1
  • MCY 1
  • Target Price
  • GRFS $10.30
  • MCY $100.00
  • AVG Volume (30 Days)
  • GRFS 779.1K
  • MCY 231.9K
  • Earning Date
  • GRFS 01-01-0001
  • MCY 11-04-2025
  • Dividend Yield
  • GRFS 1.70%
  • MCY 1.37%
  • EPS Growth
  • GRFS N/A
  • MCY N/A
  • EPS
  • GRFS 0.64
  • MCY 7.93
  • Revenue
  • GRFS $8,821,017,248.00
  • MCY $5,814,768,000.00
  • Revenue This Year
  • GRFS $5.31
  • MCY $7.13
  • Revenue Next Year
  • GRFS $6.02
  • MCY $7.60
  • P/E Ratio
  • GRFS $16.23
  • MCY $11.72
  • Revenue Growth
  • GRFS 7.31
  • MCY 5.93
  • 52 Week Low
  • GRFS $6.19
  • MCY $44.19
  • 52 Week High
  • GRFS $11.14
  • MCY $93.55
  • Technical
  • Relative Strength Index (RSI)
  • GRFS 33.65
  • MCY 78.90
  • Support Level
  • GRFS $8.33
  • MCY $87.12
  • Resistance Level
  • GRFS $8.64
  • MCY $89.92
  • Average True Range (ATR)
  • GRFS 0.21
  • MCY 2.20
  • MACD
  • GRFS -0.00
  • MCY 0.84
  • Stochastic Oscillator
  • GRFS 26.21
  • MCY 92.91

About GRFS Grifols S.A.

Grifols SA one of is global specialty plasma therapeutics companies developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. Plasma derivatives are proteins found in human plasma, which once isolated and purified, have therapeutic value. These protein-based therapies extend and enhance the lives of individuals who suffer from chronic and acute, often life-threatening, conditions, including primary and secondary immunological deficiencies, Chronic Inflammatory Demyelinating Polyneuropathy, immune-mediated ITP. Products and services are used to diagnose and treat patients with hemophilia, immune deficiencies, infectious diseases and a range of other medical conditions. Majority of revenue is from USA.

About MCY Mercury General Corporation

Mercury General Corp is an insurance holding company. It is engaged in writing personal automobile insurance and provides related property and casualty insurance products. The Company offers the following types of automobile coverage: collision, property damage, bodily injury ("BI"), comprehensive, personal injury protection ("PIP"), underinsured and uninsured motorist, and other hazards. The Company offers the following types of homeowners coverage: dwelling, liability, personal property, and other coverages.

Share on Social Networks: